Smoking and plastic surgery, part I. Pathophysiological aspects: Update and proposed recommendations

Annales de Chirurgie Plastique Esthetique

Volumn 60, Issue 1, 2015, Pages e3-e13

  Pluvy, I ^a   Garrido, I ^b   Pauchot, J ^a   Saboye, J ^b   Chavoin, J P ^b   Tropet, Y ^a   Grolleau, J L ^b   Chaput, B ^b  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b CHU RANGUEIL   (France)

Author keywords

Nicotine replacement therapy; Physiopathology; Plastic surgery; Preoperative nicotine withdrawal; Smoking; Wound healing

Indexed keywords

GANGLION STIMULATING AGENT; NICOTINE; NICOTINE GUM;

ADVERSE EFFECTS; HUMAN; HYPOXIA; ISCHEMIA; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RECONSTRUCTIVE SURGERY; SMOKING; SMOKING CESSATION; WOUND HEALING;

GANGLIONIC STIMULANTS; HUMANS; HYPOXIA; ISCHEMIA; NICOTINE; POSTOPERATIVE COMPLICATIONS; RECONSTRUCTIVE SURGICAL PROCEDURES; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; WOUND HEALING;

EID: 84922031856     PISSN: 02941260     EISSN: 1768319X     Source Type: Journal    
DOI: 10.1016/j.anplas.2014.06.011     Document Type: Short Survey

References (95)

1. Hill C., Laplanche A. Tabagisme et mortalité: aspects épidémiologiques. IGR Villejuif. Bull Epidemiol Hebd 2012.
2. Jousilahti P., Vartiainen E., Korhonen H.J., Puska P., Tuomilehto J. Is the effect of smoking on the risk for coronary heart disease even stronger than was previously thought?. J Cardiovasc Risk 1999, 6:293-298.
3. Barnes P.J. Chronic obstructive pulmonary disease. Clin Chest Med 2014, 35:71-86.
4. Siafakas N.M., Vermeire P., Pride N.B., Paoletti P., Gibson J., Howard P., et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995, 8:1398-1420.
5. Abrous N., Aubin H.J., Berlin I., Junien C., Kaminski M., et al. Tabac: comprendre la dépendance pour agir. Expertise collective. Inserm 2004, 11-44. Paris.
6. Misery L. Nicotine effects on skin: are they positive or negative?. Exp Dermatol 2004, 13:665-670.
7. International Agency for Research on Cancer Tobacco: a major international hazard 1986, 22-36. Éditeur IARC Press, Lyon, [vol n74].
8. Djordjevic M.V., Sigountos C.W., Hoffmann D., Brunnemann K.D., Kagan M.R., Bush L.P., et al. Assessment of major carcinogens and alkaloids in the tobacco and mainstream smoke of USSR cigarettes. Int J Cancer J 1991, 47:348-351.
9. Chang L.D., Buncke G., Slezak S., Buncke H.J. Cigarette smoking, plastic surgery, and microsurgery. J Reconstr Microsurg 1996, 12:467-474.
10. Sherwin M.A., Gastwirth C.M. Detrimental effects of cigarette smoking on lower extremity wound healing. J Foot Surg 1990, 29:84-87.
11. Jensen J.A., Goodson W.H., Hopf H.W., Hunt T.K. Cigarette smoking decreases tissue oxygen. Arch Surg 1991, 126:1131-1134.
12. Monfrecola G., Riccio G., Savarese C., Posteraro G., Procaccini E.M. The acute effect of smoking on cutaneous microcirculation blood flow in habitual smokers and nonsmokers. Dermatol Basel Switz 1998, 197:115-118.
13. Krupski W.C. The peripheral vascular consequences of smoking. Ann Vasc Surg 1991, 5:291-304.
14. Lelcuk S., Threlfall L., Valeri C.R., Shepro D., Hechtman H.B. Nicotine stimulates pulmonary parenchymal thromboxane synthesis. Surgery 1986, 100:836-840.
15. Krueger J.K., Rohrich R.J. Clearing the smoke: the scientific rationale for tobacco abstention with plastic surgery. Plast Reconstr Surg 2001, 108:1063-1073.
16. Khullar D., Maa J. The impact of smoking on surgical outcomes. J Am Coll Surg 2012, 215:418-426.
17. Sørensen L.T. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg 2012, 255:1069-1079.
18. Wong L.S., Martins-Green M. Firsthand cigarette smoke alters fibroblast migration and survival: implications for impaired healing. Wound Repair Regen 2004, 12:471-484.
19. Zia S., Ndoye A., Lee T.X., Webber R.J., Grando S.A. Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharmacol Exp Ther 2000, 293:973-981.
20. Yin L., Morita A., Tsuji T. Alterations of extracellular matrix induced by tobacco smoke extract. Arch Dermatol Res 2000, 292:188-194.
21. Jorgensen L.N., Kallehave F., Christensen E., Siana J.E., Gottrup F. Less collagen production in smokers. Surgery 1998, 123:450-455.
22. Knuutinen A., Kokkonen N., Risteli J., Vähäkangas K., Kallioinen M., Salo T., et al. Smoking affects collagen synthesis and extracellular matrix turnover in human skin. Br J Dermatol 2002, 146:588-594.
23. Cardoso J.F., Mendes F.A., Amadeu T.P., Romana-Souza B., Valença S.S., Porto L.C.de M.S., et al. Ccn2/Ctgf overexpression induced by cigarette smoke during cutaneous wound healing is strain dependent. Toxicol Pathol 2009, 37:175-182.
24. Su Y., Cao W., Han Z., Block E.R. Cigarette smoke extract inhibits angiogenesis of pulmonary artery endothelial cells: the role of calpain. Am J Physiol Lung Cell Mol Physiol 2004, 287:794-800.
25. Ejaz S., Insan-ud-din, Ashraf M., Nawaz M., Lim C.W., Kim B. Cigarette smoke condensate and total particulate matter severely disrupts physiological angiogenesis. Food Chem Toxicol 2009, 47:601-614.
26. Silverstein P. Smoking and wound healing. Am J Med 1992, 93:22S-24S.
27. Ernst E. Haemorheological consequences of chronic cigarette smoking. J Cardiovasc Risk 1995, 2:435-439.
28. Lundquist P., Rosling H., Sörbo B., Tibbling L. Cyanide concentrations in blood after cigarette smoking, as determined by a sensitive fluorimetric method. Clin Chem 1987, 33:1228-1230.
29. Eichel B., Shahrik H.A. Tobacco smoke toxicity: loss of human oral leukocyte function and fluid-cell metabolism. Science 1969, 166:1424-1428.
30. Toda N., Toda H. Nitric oxide-mediated blood flow regulation as affected by smoking and nicotine. Eur J Pharmacol 2010, 649:1-13.
31. Sørensen L.T., Toft B.G., Rygaard J., Ladelund S., Paddon M., James T., et al. Effect of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism. Surgery 2010, 148:982-990.
32. International Agency for Research on Cancer Tobacco smoke and involuntary smoking 2004, 89-128. Éditeur IARC Press, Lyon.
33. Schick S., Glantz S. Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972. Nicotine Tob Res 2005, 7:591-612.
34. Lee M.L., Novotny M., Bartle K.D. Gas chromatography/mass spectrometric and nuclear magnetic resonance spectrometric studies of carcinogenic polynuclear aromatic hydrocarbons in tobacco and marijuana smoke condensates. Anal Chem 1976, 48:405-416.
35. Moir D., Rickert W.S., Levasseur G., Larose Y., Maertens R., White P., et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol 2008, 21:494-502.
36. Benowitz N.L., Porchet H., Sheiner L., Jacob P. Nicotine absorption and cardiovascular effects with smokless tobacco use: comparison with cigarette and nicotine gum. Clin Pharmacol Ther 1988, 44:23-28.
37. Zevin S., Gourlay S.G., Benowitz N.L. Clinical pharmacology of nicotine. Clin Dermatol 1998, 16:557-564.
38. Benowitz N.L., Jacob P., Jones R.T., Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 1982, 221:368-372.
39. Sørensen L.T., Jørgensen S., Petersen L.J., Hemmingsen U., Bülow J., Loft S., et al. Acute effects of nicotine and smoking on blood flow, tissue oxygen, and aerobe metabolism of the skin and subcutis. J Surg Res 2009, 152:224-230.
40. Kambam J.R., Chen L.H., Hyman S.A. Effect of short-term smoking halt on carboxyhemoglobin levels and P50 values. Anesth Analg 1986, 65:1186-1188.
41. Cohendy R., Dautzenberg B., Desgrandchamps F., Dureuil B., Gayral F., et al. Tabagisme périopératoire. Conférence d'experts. Texte court 2005. Ann Fr Anesth Reamin 2006, 25:479-481.
42. Swan G.E., Hodgkin J.E., Roby T., Mittman C., Jacobo N., Peters J. Reversibility of airways injury over a 12-month period following smoking cessation. Chest 1992, 101:607-612.
43. Critchley J.A., Capewell S. WITHDRAWN: Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2012, 2:CD003041.
44. Sørensen L.T., Toft B., Rygaard J., Ladelund S., Teisner B., Gottrup F. Smoking attenuates wound inflammation and proliferation while smoking cessation restores inflammation but not proliferation. Wound Repair Regen 2010, 18:186-192.
45. Sørensen L.T. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg 2012, 147:373-383.
46. Sørensen L.T., Zillmer R., Agren M., Ladelund S., Karlsmark T., Gottrup F. Effect of smoking, abstention, and nicotine patch on epidermal healing and collagenase in skin transudate. Wound Repair Regen 2009, 17:347-353.
47. McBride C.M., Emmons K.M., Lipkus I.M. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 2003, 18:156-170.
48. Haute Autorité de Santé Recommandation de bonne pratique. Arrêt de la consommation de tabac: du dépistage individuel au maintien de l'abstinence en premier recours 2014, 5-6. Saint Denis la Plaine.
49. Anderson M.E., Belani K.G. Short-term preoperative smoking abstinence. Am Fam Physician 1990, 41:1191-1194.
50. Chang D.W., Reece G.P., Wang B., Robb G.L., Miller M.J., Evans G.R., et al. Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg 2000, 105:2374-2380.
51. Nakagawa M., Tanaka H., Tsukuma H., Kishi Y. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest 2001, 120:705-710.
52. Padubidri A.N., Yetman R., Browne E., Lucas A., Papay F., Larive B., et al. Complications of postmastectomy breast reconstructions in smokers, ex-smokers, and nonsmokers. Plast Reconstr Surg 2001, 107:342-349.
53. Kuri M., Nakagawa M., Tanaka H., Hasuo S., Kishi Y. Determination of the duration of preoperative smoking cessation to improve wound healing after head and neck surgery. Anesthesiology 2005, 102:892-896.
54. Sørensen L.T., Karlsmark T., Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg 2003, 238:1-5.
55. Sørensen L.T., Jørgensen T. Short-term preoperative smoking cessation intervention does not affect postoperative complications in colorectal surgery: a randomized clinical trial. Colorectal Dis 2003, 5:347-352.
56. Lindström D., Sadr Azodi O., Wladis A., Tønnesen H., Linder S., Nåsell H., et al. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg 2008, 248:739-745.
57. Møller A.M., Villebro N., Pedersen T., Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002, 359:114-117.
58. Campos J.H.O., Gomes H.C., dos-Santos W.L.C., Cardeal M., Ferreira L.M. Effect of nicotine treatment and withdrawal on random-pattern skin flaps in rats. Exp Toxicol Pathol 2008, 60:449-452.
59. Manchio J.V., Litchfield C.R., Sati S., Bryan D.J., Weinzweig J., Vernadakis A.J. Duration of smoking cessation and its impact on skin flap survival. Plast Reconstr Surg 2009, 124:1105-1117.
60. http://www.sfar.org/_docs/articles/PackagetabacAnesthesieSFAR2013.pdf.
61. Knobloch K., Gohritz A., Reuss E., Vogt P.M. Nicotine in plastic surgery: a review. Chirurgie 2008, 79:956-962.
62. Theadom A., Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 2006, 15:352-358.
63. Thomsen T., Tønnesen H., Møller A.M. Effect of preoperative smoking cessation interventions on postoperative complications and smoking cessation. Br J Surg 2009, 96:451-461.
64. Mills E., Eyawo O., Lockhart I., Kelly S., Wu P., Ebbert J.O. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med 2011, 124:144-154.e8.
65. Myers K., Hajek P., Hinds C., McRobbie H. Stopping smoking shortly before surgery and postoperative complications: a systematic review and meta-analysis. Arch Intern Med 2011, 171:983-989.
66. Cryer P.E., Haymond M.W., Santiago J.V., Shah S.D. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976, 295:573-577.
67. Moores L.K. Smoking and postoperative pulmonary complications. An evidence-based review of the recent literature. Clin Chest Med 2000, 21:139-146. [ix-x].
68. Buist A.S., Sexton G.J., Nagy J.M., Ross B.B. The effect of smoking cessation and modification on lung function. Am Rev Respir Dis 1976, 114:115-122.
69. Warner M.A., Offord K.P., Warner M.E., Lennon R.L., Conover M.A., Jansson-Schumacher U. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 1989, 64:609-616.
70. Møller A., Tønnesen H. Risk reduction: perioperative smoking intervention. Best Pract Res Clin Anaesthesiol 2006, 20:237-248.
71. Warner D.O. Perioperative abstinence from cigarettes: physiologic and clinical consequences. Anesthesiology 2006, 104:356-367.
72. Kotani N., Kushikata T., Hashimoto H., Sessler D.I., Muraoka M., Matsuki A. Recovery of intraoperative microbicidal and inflammatory functions of alveolar immune cells after a tobacco smoke-free period. Anesthesiology 2001, 94:999-1006.
73. Rohrich R.J. Cosmetic surgery and patients who smoke: should we operate?. Plast Reconstr Surg 2000, 106:137-138.
74. Barone M., Cogliandro A., Persichetti P. Plastic surgery and smoking: a prospective analysis of incidence, compliance, and complications. Plast Reconstr Surg 2013, 132:686e-687e.
75. Benowitz N.L. Nicotine addiction. N Engl J Med 2010, 362:2295-2303.
76. Berlin I. Pharmacologie clinique du tabagisme. Traité d'addictologie 2006, 437-441. Flammarion, Paris.
77. Warner D.O. Helping surgical patients quit smoking: why, when, and how. Anesth Analg 2005, 101:481-487.
78. Stead L.F., Perera R., Bullen C., Mant D., Hartmann-Boyce J., Cahill K., et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012, 11:CD000146.
79. Cahill K., Stevens S., Perera R., Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013, 5:CD009329.
80. Russell M.A. Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br Med J 1976, 1:1430-1433.
81. Joseph A.M., Norman S.M., Ferry L.H., Prochazka A.V., Westman E.C., Steele B.G., et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996, 335:1792-1798.
82. Greenland S., Satterfield M.H., Lanes S.F. A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf 1998, 18:297-308.
83. Tzivoni D., Keren A., Meyler S., Khoury Z., Lerer T., Brunel P. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998, 12:239-244.
84. Benowitz N.L., Gourlay S.G. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997, 29:1422-1431.
85. Fulcher S.M., Koman L.A., Smith B.P., Holden M., Smith T.L. The effect of transdermal nicotine on digital perfusion in reformed habitual smokers. J Hand Surg 1998, 23:792-799.
86. Netscher D.T., Wigoda P., Thornby J., Yip B., Rappaport N.H. The hemodynamic and hematologic effects of cigarette smoking versus a nicotine patch. Plast Reconstr Surg 1995, 96:681-688.
87. Henningfield J.E. Nicotine medications for smoking cessation. N Engl J Med 1995, 333:1196-1203.
88. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 1991, 86:1119-1127.
89. Tønnesen H. Surgery and smoking at first and second hand: time to act. Anesthesiology 2011, 115:1-3.
90. Agence française de sécurité sanitaire des produits de santé Les stratégies thérapeutiques médicamenteuses et non médicamenteuses de l'aide à l'arrêt du tabac 2003, 3-6. Saint Denis la Plaine.
91. Haute Autorité de Santé Stratégies thérapeutiques d'aide au sevrage tabagique 2007, 1-6. Saint Denis la Plaine.
92. Thomsen T., Villebro N., Møller A.M. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev 2010, CD002294.
93. AFSSAPS Compte rendu de la réunion de la commission nationale des stupéfiants et des psychotropes 2010, 5-10. Saint Denis La Plaine.
94. Pepper J.K., Brewer N.T. Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review. Tob Control 2013.
95. Bullen C., Howe C., Laugesen M., McRobbie H., Parag V., Williman J., et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013, 382:1629-1637.